| [1] |
Bodey B. Thymic reticulo-epithelial cells: key cells of neuroendocrine regulation[J]. Expert Opin Biol Ther, 2007, 7(7): 93 9-49.
|
| [2] |
Wang Y, Zhang YC, Han XC. Expression of oncogenic signal transducers and activator of transcription 5 (STAT5) in human hepatic tissue and its signifi cance[J]. Mian Yi Xue Za Zhi, 2009, 25 (1):75-6. [王禹,张颖超,韩喜春. 癌基因STAT5在肝细胞肝癌 中的表达和意义[J].免疫学杂志,2009,25(1):75-6.]
|
| [3] |
Furth PA, Nakles RE, Millman S,et al. Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer[J]. Breast Cancer Res, 2011,13(5): 220.
|
| [4] |
Hou LL, Wang LP, Hu FY, et al. Clinical significance of the expression of STAT5a, STAT5b in human non small cell lung cancer[J]. Zhongguo Mian Yi Xue Za Zhi,2010, 26(11): 1029-32. [侯莉莉,王乐朋,胡福英,等. STAT5a和STAT5b蛋白在非小细胞 肺癌中的表达及临床意义[J]. 中国免疫学杂志, 2010, 26(11): 10 29-32.]
|
| [5] |
Koptyra M, Gupta S, Talati P, et al. Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer [J]. Int J Biochem Cell Biol, 2011, 43 (10):1417-21.
|
| [6] |
Lai SY, Johnson FM. Defi ning the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches [J]. Drug Resist Updat, 2010, 13 (3):67-78.
|
| [7] |
Woolley JF, Naughton R, Stanicka J, et al. H2O2 production downstream of FLT3 is mediated by p22phox in the endoplasmic reticulum and is required for STAT5 signalling [J]. PLoS One, 20 12,7(7): e34050.
|
| [8] |
Murray PJ. The JAK-STAT signaling pathway: input and output integration[J]. J Immunol, 2007, 178(5):2623-9.
|
| [9] |
Sánchez-Ceja SG, Reyes-Maldonado E, Vázquez-Manríquez ME, et al. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma [J]. Lung Cancer, 2006, 54(2):163-8.
|
| [10] |
de Groot RP, Raaijmakers JA, Lammers JW, et al. STAT5- Dependent CyclinD1 and Bcl-xL expression in Bcr-Abltransformed cells[J]. Mol Cell Biol Res Commun,2000, 3( 5):299-305.
|
| [11] |
Moon JJ, Rubio ED, Martino A, et al. A permissive role for phosphatidylinositol 3-kinase in the Stat5-mediated expression of cyclin D2 by the interleukin-2 receptor[J]. J Biol Chem, 2004, 27 9(7):5520-7.
|
| [12] |
Tan SH, Nevalainen MT. Signal transducer and activator of transcription 5A/B in prostate and breast cancers [J]. Endocr Relat Cancer, 2008, 15(2):367-90.
|
| [13] |
Diaz T, Navarro A, Ferrer G, et al. Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis[J]. PLoS One,2011, 6(4): e18856.
|
| [14] |
Duan Z, Zhu GX, Xue X, et al. Infl uence of STAT5 siRNA on Hela cell proliferation and apoptosis and its molecular mechanism[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2009, 14(10): 879-83. [段钊， 主改侠，薛翔，等. siRNA沉默STAT5对HeLa细胞增殖和凋亡 的影响及分子机制[J].临床肿瘤学杂志, 2009, 14(10): 879-83.]
|
| [15] |
Daoxin Jin, Wenqiao Zang, Tao Wang, et al. The effect of STAT5 silenced by siRNA on proliferation, apoptosis and invasion of esophageal carcinoma cell line EC9706[J]. Chinese-German J Clin Oncol,2010, 9(12): 692-6.
|
| [16] |
Holen T, Amarzguioui M, Wiiger MT,et al. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor[J]. Nucleic Acids Res, 2002, 30(8): 1757-66.
|
| [17] |
Gong D, Ferrell JE Jr. Picking a winner: new echanistic insights into the design of fective siRNAs[J]. Trends Biotechnol, 2004, 22 (9): 451-4.
|
| [18] |
Zeng YQ, Shui QL, Zhao J, et al. Positional and time effects of specific siRNA inhibit the expression of hTERT[J].Yi Chuan,2008,30(7):857-62. [曾永秋,税青林,赵矫,等.特异性 siRNA抑制hTERT基因表达的位置及时间效应[J]. 遗传,2008, 30 (7): 857-62.]
|
下载:
